Tumor Glycosylation: A Main Player in the Modulation of Immune Responses
European Journal of Immunology · 2025-03 · 55 (3)
DOI: 10.1002/eji.202451318 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 12.03.2025. Verfasst von Ernesto Rodriguez. Beteiligte Einrichtung: Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Neoplasms, Tumor Escape. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tumor immune escape refers to the process by which cancer cells evade detection and destruction by the immune system. Glycosylation, a post‐translational modification that is altered in almost all cancer types, plays a crucial role in this process by modulating immune responses. This review examines our current understanding of how aberrant tumor glycosylation contributes to a tolerogenic microenvironment, focusing on specific glycosylation signatures—fucosylation, truncated O‐glycans, and sialylation—and the immune receptors involved. Additionally, the clinical significance of tumor glycosylation is discussed, emphasizing its potential in developing novel therapeutic approaches aimed at improving immune system recognition and targeting of cancer cells. The review underscores the importance of ongoing research in this area to identify effective strategies for countering tumor immune escape and enhancing the efficacy of cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amsterdam UMC location Vrije Universiteit Amsterdam, Molecular Cell Biology and Immunology, Amsterdam, The Netherlands.
- Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.
- Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
Zitieren
APA
Rodriguez, E. (2025). Tumor Glycosylation: A Main Player in the Modulation of Immune Responses. European Journal of Immunology, 55(3). https://doi.org/10.1002/eji.202451318
Vancouver
Rodriguez E. Tumor Glycosylation: A Main Player in the Modulation of Immune Responses. European Journal of Immunology. 2025;55(3). doi:10.1002/eji.202451318
BibTeX
@article{Rodriguez2025,
author = {Rodriguez, Ernesto},
title = {Tumor Glycosylation: A Main Player in the Modulation of Immune Responses},
journal = {European Journal of Immunology},
year = {2025},
volume = {55},
number = {3},
doi = {10.1002/eji.202451318}
}
EUVIMED